Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Gliatech initiates ADCON-P pivotal clinical trial

Jan. 29, 1999

Vertex initiates phase II psoriasis trial of VX-497

Jan. 22, 1999

Adolor receives additional patent protection for ADL-2-1294

Jan. 21, 1999

ProCyte and Merck enter distribution agreement

Jan. 20, 1999

Roche presents new compound for hyperproliferative skin disorders

Jan. 19, 1999

Promising results reported from pilot studies of MaxDerm in several skin conditions

Jan. 12, 1999

Xoma completes phase II development of hu1124; Genentech will decide future course

Jan. 11, 1999

Prodrug glucocorticoid NM-135 displays potent antiinflammatory activity, good side effect profile

Jan. 7, 1999

AxyS initiates phase I clinical trial of APC-2059 for treatment of psoriasis

Jan. 7, 1999

Novel compounds synthesized at BMS particularly useful for prevention of postsurgical adhesions

Jan. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026